Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids

B. Ebert, F. Bari, D. Snead, D. Mitchell (Coventry, United Kingdom)

Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Session: Translational research to bridge the need within clinical decision making
Session type: Thematic Poster Session
Number: 535
Disease area: Interstitial lung diseases, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Ebert, F. Bari, D. Snead, D. Mitchell (Coventry, United Kingdom). Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids. Eur Respir J 2013; 42: Suppl. 57, 535

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Correlation between clinical and pathological factors in resected lung carcinoid tumours
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013



Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

The proteasome subunits PSMA5 and PSMB4 are potent markers to discriminate between typical and atypical carcinoid tumors of the lung
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Primary lung sarcomas and sarcomatoid carcinomas – Clinicopathological prognostic factors in operated patients
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Intrathoracic mass as an initial presentation of follicular carcinoma of thyroid: A rare entity
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



Regulation and localization of the telomerase enzyme-complex and the shelterin-telosom-complex in sporadic idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Multiple endobronchial involvement of Mantle cell lymphoma diagnosed by cryobiopsy
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Incidence, outcomes and risk factors for neoplasms in explanted lungs
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014


Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021
Year: 2022



Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015